Related Experiment Video

Updated: Apr 15, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

858

miRNA - Therapeutic tool in breast cancer? Where are we now?

Karolina Zaleska1

  • 1Radiobiology Laboratory in the Medical Physics Department, Greater Poland Cancer Centre, Poznan, Poland.

Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
|April 11, 2015
PubMed
Abstract

Insights

MicroRNAs (miRNAs) are small molecules playing a key role in breast cancer development and progression. These circulating miRNAs show potential as diagnostic, prognostic, and therapeutic tools for personalized cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are small RNA molecules integral to cellular processes.
  • Dysregulation of miRNAs is implicated in various diseases, including cancer.
  • Breast cancer is a prevalent malignancy with diverse subtypes and treatment responses.

Purpose of the Study:

  • To review current knowledge on microRNA involvement in breast cancer.
  • To explore the clinical potential of microRNAs in breast cancer management.
  • To consolidate findings from scientific literature up to March 2014.

Main Methods:

  • Systematic literature review.
  • Database search (PubMed/Medline).
  • Analysis of published studies on microRNAs and breast cancer.

Main Results:

  • MicroRNAs play a critical role in tumor initiation and progression.
  • Circulating miRNAs are identifiable and promising tumor biomarkers.
  • MicroRNAs demonstrate potential as diagnostic, prognostic, and therapeutic agents in breast cancer.

Conclusions:

  • Understanding molecular mechanisms, including miRNA roles, is vital for effective cancer therapy.
  • MicroRNAs hold significant promise for advancing anticancer treatments.
Keywords:
BiomarkersBreast cancerTumourigenesismiRNA

More Related Videos

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

7.2K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

6.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K